Ascelia: Type A Meeting decides the path - Redeye
Bildkälla: Stockfoto

Ascelia: Type A Meeting decides the path - Redeye

Redeye returns with an update following the CRL and additional consideration, where we lower the likelihood of approval, include an assumed rights issue, and a later deal and launch. We cut our Fair Value, which also takes peer valuation into account, to SEK1 per share - which screens fairly valued.

Redeye returns with an update following the CRL and additional consideration, where we lower the likelihood of approval, include an assumed rights issue, and a later deal and launch. We cut our Fair Value, which also takes peer valuation into account, to SEK1 per share - which screens fairly valued.
Börsvärldens nyhetsbrev